Basic information |
Metabolite name | Acetoacetic acid |
HMDB0000060 | |
C00164 | |
96 | |
Synonyms | acetoacetate |
No. of studies | 14 |
Relationship between Acetoacetic acid and depression (count: 14) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M026 | Type1 | CUMS group vs. control group | Urine | Wistar rat | Down |
Study M027 | Type1 | CUMS group vs. control group | Urine | Wistar rat | Down |
Study M027 | Type2 | CUMS + CSGS group vs. CUMS group | Urine | Wistar rat | Up |
Study M030 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
Study M053 | Type1 | CUMS group vs. control group | Urine | Wistar rat | Up |
Study M053 | Type2 | CUMS + CSGS group vs. CUMS group | Urine | Wistar rat | Down |
Study M058 | Type1 | depressed HBV-infected patients group vs. control group and non-depressed HBV-infected group | Urine | Human | Down |
Study M066 | Type1 | CUMS vs. control group | Plasma | Sprague-Dawley rat | Up |
Study M066 | Type2 | CUMS + middle dose of YHTA group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
Study M066 | Type2 | CUMS + low dose of YHTA group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
Study M066 | Type2 | CUMS + high dose of YHTA group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
Study M089 | Type3 | fluoxetine vs. control group | Plasma | Rhesus monkey | Down |
Study M1044 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
Study M120 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
Study M207 | Type1 | depressed group vs. control group | Faece | Kunming mouse | Up |
Study M577 | Type1 | male depression group vs. male control group, aged 30-39 | Urine | Human | Unknown |
Study M614 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
Study M739 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |